Biological Signal Processing Ltd. (Tel Aviv, Israel) received FDA clearance for its high-resolution ECG technology to be used to diagnose heart attacks, according to the Globes newspaper. HyperQ, as it’s called, the technology gives a much closer look at the QRS complex of an ECG, which holds clues about the patient’s cardiac condition.
Previously, the technology was intended for use during a traditional stress test, aiding in more accurately assessing the patient’s cardiopulmonary health.
Help employers find you! Check out all the jobs and post your resume.
Previously, the technology was intended for use during a traditional stress test, aiding in more accurately assessing the patient’s cardiopulmonary health.
Help employers find you! Check out all the jobs and post your resume.
